|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4245 | |
| A61K 31/352 | |||
| A61K 31/4025 | |||
| A61P 25/00 | |||
| A61P 25/28 | |||
| A61P 25/24 | |||
| A61P 25/20 | |||
| C07D 413/14 |
| (11) | Number of the document | 2948143 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14743158.9 |
| Date of filing the European patent application | 2014-01-24 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/013026 |
| Date | 2014-01-24 |
| (87) | Number | WO 2014/117003 |
| Date | 2014-07-31 |
| (30) | Number | Date | Country code |
| 201361756208 P | 2013-01-24 | US | |
| 201361799482 P | 2013-03-15 | US | |
| 201361852149 P | 2013-03-15 | US |
| (72) |
PELLEGRINI, Lorenzo, US
KARABELAS, Argeris, US
LUTHRINGER, Remy, CH
|
| (73) |
Minerva Neurosciences, Inc.,
1601 Trapelo Road, Suite 284, Waltham, MA 02451,
US
|
| (54) | USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION |
| USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION |